Natasha Szuber

2.1k total citations
57 papers, 1.1k citations indexed

About

Natasha Szuber is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Natasha Szuber has authored 57 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 43 papers in Hematology and 21 papers in Molecular Biology. Recurrent topics in Natasha Szuber's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (49 papers), Acute Myeloid Leukemia Research (24 papers) and Kruppel-like factors research (19 papers). Natasha Szuber is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (49 papers), Acute Myeloid Leukemia Research (24 papers) and Kruppel-like factors research (19 papers). Natasha Szuber collaborates with scholars based in Canada, United States and Italy. Natasha Szuber's co-authors include Ayalew Tefferi, Naseema Gangat, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Terra L. Lasho, Christy M. Finke, Lambert Busque, Luigina Mollica and Manuel Buscarlet and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Natasha Szuber

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natasha Szuber Canada 16 894 860 504 266 68 57 1.1k
Emmanuelle Verger France 15 468 0.5× 432 0.5× 299 0.6× 202 0.8× 39 0.6× 34 663
Aline Massé France 10 419 0.5× 502 0.6× 581 1.2× 168 0.6× 23 0.3× 23 904
Jean Michel Cayuela France 10 411 0.5× 481 0.6× 132 0.3× 245 0.9× 66 1.0× 12 727
Agnès Guerci‐Bresler France 18 1.1k 1.3× 1.4k 1.6× 125 0.2× 546 2.1× 28 0.4× 53 1.5k
Emilie Leroy Belgium 13 514 0.6× 385 0.4× 315 0.6× 150 0.6× 12 0.2× 19 650
L. Knoops Belgium 7 426 0.5× 338 0.4× 281 0.6× 155 0.6× 31 0.5× 13 628
Alessia Moro Italy 11 259 0.3× 206 0.2× 180 0.4× 109 0.4× 28 0.4× 20 424
Marianne Rosamilia United States 5 309 0.3× 483 0.6× 163 0.3× 215 0.8× 51 0.8× 7 684
J. Janssen Netherlands 9 222 0.2× 285 0.3× 75 0.1× 111 0.4× 31 0.5× 11 412
Els Lierman Belgium 10 156 0.2× 191 0.2× 154 0.3× 207 0.8× 33 0.5× 19 453

Countries citing papers authored by Natasha Szuber

Since Specialization
Citations

This map shows the geographic impact of Natasha Szuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Szuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Szuber more than expected).

Fields of papers citing papers by Natasha Szuber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Szuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Szuber. The network helps show where Natasha Szuber may publish in the future.

Co-authorship network of co-authors of Natasha Szuber

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Szuber. A scholar is included among the top collaborators of Natasha Szuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Szuber. Natasha Szuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouellet, Marie, Luigina Mollica, Geneviève Chabot‐Roy, et al.. (2026). MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms. Blood Advances. 10(7). 2142–2152.
2.
Tefferi, Ayalew, Naseema Gangat, Giuseppe Gaetano Loscocco, et al.. (2025). Essential Thrombocythemia. JAMA. 333(8). 701–701. 3 indexed citations
3.
4.
Szuber, Natasha, Paola Guglielmelli, & Naseema Gangat. (2025). Topics of Interest in Women With Myeloproliferative Neoplasms. American Journal of Hematology. 100(S4). 74–87. 1 indexed citations
5.
Szuber, Natasha, Harold J. Olney, Steve Dagenais-Bellefeuille, et al.. (2024). Perioperative outcomes in patients with myeloproliferative neoplasms: a multicentric analysis of 354 surgical procedures. PubMed. 1(4). 100026–100026. 1 indexed citations
6.
Dagenais-Bellefeuille, Steve, Karine Bilodeau, Shireen Sirhan, et al.. (2024). Understanding the Lived Experience of Fatigue in Adolescents and Young Adults with Myeloproliferative Neoplasms: A Mixed Methods Study. Blood. 144(Supplement 1). 408–408.
7.
Guglielmelli, Paola, Natasha Szuber, Naseema Gangat, et al.. (2024). CALR mutation burden in essential thrombocythemia and disease outcome. Blood. 143(13). 1310–1314. 2 indexed citations
8.
Szuber, Natasha, Attilio Orazi, & Ayalew Tefferi. (2024). Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management. American Journal of Hematology. 99(7). 1360–1387. 9 indexed citations
9.
Tefferi, Ayalew, Giuseppe Gaetano Loscocco, Animesh Pardanani, et al.. (2024). Monocytosis Is an Independent Risk Factor for Survival in Essential Thrombocythemia - a Revised Triple-a Prognostic Score (AAA+A) Based on Age and Absolute Monocyte, Neutrophil, and Lymphocyte Counts. Blood. 144(Supplement 1). 3169–3169. 1 indexed citations
10.
Gangat, Naseema, Natasha Szuber, & Ayalew Tefferi. (2023). JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management. American Journal of Hematology. 98(6). 965–981. 27 indexed citations
11.
Tefferi, Ayalew, Giuseppe Gaetano Loscocco, Natasha Szuber, et al.. (2023). A globally applicable “triple A” risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count. American Journal of Hematology. 98(12). 1829–1837. 18 indexed citations
12.
Szuber, Natasha, Steve Dagenais-Bellefeuille, Jaroslav F. Prchal, et al.. (2023). Perioperative Outcomes and Management in Patients with Myeloproliferative Neoplasms: A Multicentric Retrospective Analysis of 354 Surgical Interventions. Blood. 142(Supplement 1). 3183–3183. 1 indexed citations
13.
Gangat, Naseema, Paola Guglielmelli, Natasha Szuber, et al.. (2021). Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American Journal of Hematology. 96(7). 781–789. 39 indexed citations
14.
Szuber, Natasha & Ayalew Tefferi. (2021). Current Management of Chronic Neutrophilic Leukemia. Current Treatment Options in Oncology. 22(7). 59–59. 3 indexed citations
15.
Ruan, Gordon, Courtney N. Day, William S. Harmsen, et al.. (2020). A population-based study of chronic neutrophilic leukemia in the United States. Blood Cancer Journal. 10(6). 68–68. 10 indexed citations
16.
Tefferi, Ayalew, Paola Guglielmelli, Terra L. Lasho, et al.. (2020). Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera. British Journal of Haematology. 189(2). 291–302. 134 indexed citations
17.
Gangat, Naseema, Mythri Mudireddy, Terra L. Lasho, et al.. (2018). Mutations and prognosis in myelodysplastic syndromes: karyotype‐adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model. American Journal of Hematology. 93(5). 691–697. 42 indexed citations
18.
Tefferi, Ayalew, Natasha Szuber, Rangit Vallapureddy, et al.. (2018). Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide. American Journal of Hematology. 94(1). 5–9. 9 indexed citations
19.
Szuber, Natasha & Ayalew Tefferi. (2018). Chronic neutrophilic leukemia: new science and new diagnostic criteria. Blood Cancer Journal. 8(2). 19–19. 16 indexed citations
20.
Buscarlet, Manuel, Sylvie Provost, Yassamin Feroz Zada, et al.. (2017). DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood. 130(6). 753–762. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuelle Verger Breakdown of academic impact, for papers by Aline Massé Breakdown of academic impact, for papers by Jean Michel Cayuela Breakdown of academic impact, for papers by Agnès Guerci‐Bresler Breakdown of academic impact, for papers by Emilie Leroy Breakdown of academic impact, for papers by L. Knoops Breakdown of academic impact, for papers by Alessia Moro Breakdown of academic impact, for papers by Marianne Rosamilia Breakdown of academic impact, for papers by J. Janssen Breakdown of academic impact, for papers by Els Lierman
Rankless by CCL
2026